Yabao Pharmaceutical Group Co., Ltd (SHA:600351)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical Production	2.03B						2.43B	2.12B	1.32B
Medical Production Growth	-						14.40%	60.39%	-19.61%
Wholesale of Medicine	574.03M						455.84M	397.05M	459.61M
Wholesale of Medicine Growth	-						14.81%	-13.61%	16.32%
Other Trade	50.59M						11.79M	30.24M	10.66M
Other Trade Growth	-						-61.00%	183.73%	1.72%
Total	2.65B						2.90B	2.55B	1.79B
Total Growth	-						13.57%	42.17%	-12.58%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Northeast China Region	186.69M						214.68M	188.82M	101.26M
Northeast China Region Growth	-						13.69%	86.47%	-21.14%
North China	1.05B						778.11M	671.62M	704.61M
North China Growth	-						15.86%	-4.68%	6.74%
East China	467.07M						805.98M	798.22M	396.59M
East China Growth	-						0.97%	101.27%	7.53%
Central China Region	299.42M						369.35M	318.76M	239.21M
Central China Region Growth	-						15.87%	33.25%	-38.74%
Southwest Region	264.75M						268.76M	227.90M	131.80M
Southwest Region Growth	-						17.93%	72.91%	-45.18%
Export	8.23M						5.30M	4.66M	1.07M
Export Growth	-						13.58%	335.38%	-74.80%
Southern China	212.94M						261.29M	207.60M	121.56M
Southern China Growth	-						25.86%	70.78%	-21.26%
Northwestern Region	160.69M						194.16M	133.86M	98.53M
Northwestern Region Growth	-						45.04%	35.86%	-7.18%
Total	2.65B						2.90B	2.55B	1.79B
Total Growth	-						13.57%	42.17%	-12.58%

Source: S&P Global Market Intelligence.